Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67101 - 67125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	INHBE	83729	downregulated	rosiglitazone results in decreased expression of INHBE mRNA	12q13.3	A22609
Rosiglitazone	Approved Investigational	INPP5F	22876	upregulated	rosiglitazone results in increased expression of INPP5F mRNA	10q26.11	A10216
Rosiglitazone	Approved Investigational	INS	3630	upregulated	rosiglitazone results in increased expression of INS mRNA	11p15.5	A23573
Rosiglitazone	Approved Investigational	INSIG1	3638	downregulated	rosiglitazone results in decreased expression of INSIG1 mRNA	7q36.3	A22609
Rosiglitazone	Approved Investigational	INSIG2	51141	downregulated	rosiglitazone results in decreased expression of INSIG2 mRNA	2q14.1-q14.2	A20427
Rosiglitazone	Approved Investigational	IPCEF1	26034	downregulated	rosiglitazone results in decreased expression of IPCEF1 mRNA	6q25.2	A10216
Rosiglitazone	Approved Investigational	ISCA1	81689	upregulated	rosiglitazone results in increased expression of ISCA1 mRNA	9q21.33	A22609
Rosiglitazone	Approved Investigational	ISG20	3669	downregulated	rosiglitazone results in decreased expression of ISG20 mRNA	15q26.1	A22609
Rosiglitazone	Approved Investigational	ITGAE	3682	upregulated	rosiglitazone results in increased expression of ITGAE mRNA	17p13.2	A10216
Rosiglitazone	Approved Investigational	IYD	389434	downregulated	rosiglitazone results in decreased expression of IYD mRNA	6q25.1	A22609
Rosiglitazone	Approved Investigational	KEAP1	9817	upregulated	rosiglitazone results in increased expression of KEAP1 mRNA	19p13.2	A20427
Rosiglitazone	Approved Investigational	KIAA0040	9674	downregulated	rosiglitazone results in decreased expression of KIAA0040 mRNA	1q25.1	A10216
Rosiglitazone	Approved Investigational	KIAA1161	57462	downregulated	rosiglitazone results in decreased expression of KIAA1161 mRNA	9p13.3	A10216
Rosiglitazone	Approved Investigational	KIFC2	90990	downregulated	rosiglitazone results in decreased expression of KIFC2 mRNA	8q24.3	A10216
Rosiglitazone	Approved Investigational	KLKB1	3818	downregulated	rosiglitazone results in decreased expression of KLKB1 mRNA	4q35.2	A22609
Rosiglitazone	Approved Investigational	KMO	8564	downregulated	rosiglitazone results in decreased expression of KMO mRNA	1q43	A22609
Rosiglitazone	Approved Investigational	LAIR1	3903	upregulated	rosiglitazone results in increased expression of LAIR1 mRNA	19q13.42	A10216
Rosiglitazone	Approved Investigational	LAMA4	3910	upregulated	rosiglitazone results in increased expression of LAMA4 mRNA	6q21	A22609
Rosiglitazone	Approved Investigational	LDLR	3949	downregulated	rosiglitazone results in decreased expression of LDLR mRNA	19p13.2	A24095
Rosiglitazone	Approved Investigational	LDLRAD4	753	upregulated	rosiglitazone results in increased expression of LDLRAD4 mRNA	18p11.21	A10216
Rosiglitazone	Approved Investigational	LEAP2	116842	downregulated	rosiglitazone results in decreased expression of LEAP2 mRNA	5q31.1	A22609
Rosiglitazone	Approved Investigational	LELP1	149018	downregulated	rosiglitazone results in decreased expression of LELP1 mRNA	1q21.3	A10216
Rosiglitazone	Approved Investigational	LEP	3952	downregulated	rosiglitazone results in decreased expression of LEP mRNA	7q32.1	A4815 A19957
Rosiglitazone	Approved Investigational	LEP	3952	upregulated	rosiglitazone results in increased expression of LEP mRNA	7q32.1	A24122 A24098
Rosiglitazone	Approved Investigational	LILRA1	11024	upregulated	rosiglitazone results in increased expression of LILRA1 mRNA	19q13.42	A10216

Displaying entries 67101 - 67125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability